XenoGesis Ltd. is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism & pharmacokinetics (DMPK), quantitative bioanalysis and expert interpretation. The core XenoGesis team has an enviable track record of delivery in drug discovery.
It is clear that identifying poor compounds early through scientific rigor is key in preventing progression into more expensive pre-clinical tests. Even a minor improvement in early-stage drug failure prediction will result in significant time and cost savings for R&D companies. Specifically,XenoGesis can identify the potential 'winners' and 'losers' in a selection of compounds synthesised in drug discovery campaigns. Moreover, providing iterative feedback to the research team based on the results and recommending next steps is a key focus for XenoGesis.
Highly experienced, immediately effective and proven at every level. YourEncore has built a network of experts that bring deep technical know-how and a track record of results, serving 21 of the top 25 pharmaceutical companies and 5 of the top 9 consumer and food companies. We also serve a growing number of small and mid-size companies. Our experts help clients accelerate innovation, navigate complex regulatory environments and unlock productivity improvements, helping companies bring products to market that lead to happier, healthier lives.